Report overview
There are two types of PRRS vaccines that are commercially available. One is a modified-live virus (MLV) vaccine and the other is a killed virus (KV) vaccine. PRRS MLV vaccine is well recognized for its protective efficacy against PRRSV that are genetically homologous to the vaccine virus.
This report aims to provide a comprehensive presentation of the global market for PRRS Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PRRS Vaccines. This report contains market size and forecasts of PRRS Vaccines in global, including the following market information:
Global PRRS Vaccines Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global PRRS Vaccines Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five PRRS Vaccines companies in 2022 (%)
The global PRRS Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Live Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of PRRS Vaccines include CAHIC, Merial, MSD Animal Health, Chopper Biology, Ceva, ChengDu Tecbond, Veterinary, Ringpu Biology and Qilu Animal, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the PRRS Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PRRS Vaccines Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global PRRS Vaccines Market Segment Percentages, by Type, 2022 (%)
Live Vaccines
Killed Vaccines
Global PRRS Vaccines Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global PRRS Vaccines Market Segment Percentages, by Application, 2022 (%)
Government Tender
Market Sales
Global PRRS Vaccines Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global PRRS Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PRRS Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies PRRS Vaccines revenues share in global market, 2022 (%)
Key companies PRRS Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies PRRS Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Zoetis
Outline of Major Chapters:
Chapter 1: Introduces the definition of PRRS Vaccines, market overview.
Chapter 2: Global PRRS Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of PRRS Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of PRRS Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global PRRS Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
